Načítá se...
Hematopoietic stem cell transplantation in patients with myelodysplastic syndrome
Hematopoietic stem cell transplantation (HSCT) is the only curative therapy for patients with myelodysplastic syndrome (MDS). However, the morbidity and mortality associated with conventional HSCT have traditionally prevented many patients from undergoing such treatment. Recent advances, including b...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medicine Reports Ltd
2009
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2920696/ https://ncbi.nlm.nih.gov/pubmed/20948771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3410/M1-11 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|